News

Under the terms of the agreement, Forest will make an upfront payment to Mylan of $75 million as well as potential future milestone payments. In addition, Mylan will

NicAlert gives a visual read-out of the level of tobacco use or exposure within minutes and requires no instruments to use. NicAlert has received clearance from the FDA

The decision has also fueled speculation that Novartis may be planning a giant bid for Serono SA with shares in the Swiss biotech company rising to a three

TZP-101 is targeted at ghrelin, a peptide hormone secreted by the stomach and small intestine which plays a physiological role in the stimulation of gastrointestinal (GI) motility. Animal

Cephalon will grant Mylan a non-exclusive royalty-bearing right to market and sell a generic version of Provigil in the US from October 2011, unless Cephalon obtains a pediatric

Caprion will contribute a selection of cancer targets that it has discovered using its proprietary CellCarta proteomics technology platform. ImClone Systems will have exclusive, worldwide rights to develop

An orphan drug designation confers a number of benefits including ten years of potential market exclusivity if the product candidate is approved for marketing in the EU, and

The payment was made pursuant to an agreement between the companies reached in October 2004, under which GSK acquired exclusive worldwide rights to develop and commercialize GSK716155 for

Under terms of the agreement, CoGenesys is entitled to an upfront licensing fee, development milestone payments and royalties on future sales of antibody therapeutics developed by PDL against